Tapan Maniar, Ph.D.
Dr. Maniar joined Bain Capital Life Sciences in September 2021. Prior to Bain Capital, he was at Genentech from 2017 to 2021, taking on the role of Genentech’s Head of Business Development for drug discovery technologies. During his tenure, Dr. Maniar led or oversaw 10+ transactions, expanding Genentech’s access to innovative modalities and technologies across therapeutic areas. Previously, he was a senior Engagement Manager at McKinsey & Co, where he advised biopharmaceutical and healthcare organizations on a range of strategic topics across BD, R&D and commercial value and access.
Dr. Maniar earned his Ph.D. in Neuroscience at The Rockefeller University from Cori Bargmann’s lab, where he investigated the genetic and molecular basis of neuronal development. He received his B.A. in Biology from Bard College.